does allulose increase glp-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 Release by Rare Sugar

All gastrointestinal adverse events (GI AEs) were mild, except for one participant who reported two moderate events (nausea and vomiting) and discontinued treatment after the third administration

Amylin and hypertension: association of an amylin-G132A gene mutation and hypertension in humans and amylin-induced endothelium dysfunction in rats

2024: Usage and spending trends and outlook to 2028

GLP-1 RA therapy was linked to 15%26% lower risks of cholangitis, bowel obstruction, ileus, volvulus, chronic pancreatitis, and procedures such as endoscopic retrograde cholangiopancreatography compared to other oral antidiabetic drugs